Patents
Patents for C07J 13 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having a carbon-to-carbon double bond from or to position 17 (764)
08/2009
08/06/2009WO2009096445A1 Nerve trunk cell propagation accelerator
08/05/2009EP2083621A2 Modulators of amyloid-beta production
08/05/2009EP1620455A4 Process for preparing guggulsterones and guggulsterol
08/04/2009CA2523369C Process for preparing guggulsterones and guggulsterol
07/2009
07/22/2009CN101486749A Method for synthesizing 4 alpha-amido-5 alpha- androstane-3,17-dione compound
06/2009
06/17/2009EP2069383A2 Synthetic bile acid composition, method, and preparation
06/09/2009CA2512508C Process for preparing guggulsterones
06/04/2009WO2009035527A3 Levonorgestrel crystallization
06/04/2009WO2008157635A3 Synthetic bile acid composition, method, and preparation
05/2009
05/22/2009WO2008110941A3 New process of synthesis of a squalamine and/or trodusquemine precursor
05/21/2009US20090131389 Preparation of a Crystalline Antibiotic Substance
05/12/2009CA2315829C Angiostatic agents and compositions for controlling ocular hypertension
03/2009
03/19/2009WO2009035527A2 Levonorgestrel crystallization
01/2009
01/21/2009CN101351471A Preparation of a crystalline antibiotic substance
12/2008
12/24/2008WO2008157635A2 Synthetic bile acid composition, method, and preparation
12/24/2008CA2789109A1 Synthetic bile acid composition, method, and preparation
12/02/2008US7459141 Technetium-99m-labeled organic germanium nanocolloids, method of preparing the same and use thereof
07/2008
07/23/2008EP1945654A2 Preparation of an antibiotic crystalline fusidic acid
07/22/2008CA2458932C Methylene-4-azasteroids
06/2008
06/11/2008CN101195648A Method for producing diene sterone
06/10/2008CA2259981C 6,7-oxygenated steroids and uses related thereto
06/04/2008EP1927359A2 2-Methoxyestradiol for the treatment of inflammatory disorders
05/2008
05/13/2008US7371741 Angiogenesis inhibitor
04/2008
04/29/2008US7365218 Process for preparing guggulsterones
04/09/2008CN100379753C Intermediates for 16 beta -methyl steroids
02/2008
02/27/2008CN101130567A Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
02/13/2008CN100368425C 6,7-oxygenated steroids and uses related thereto
01/2008
01/31/2008WO2008012833A1 A process for the preparation of 16-dehydropregenolone acetate ( 16-dpa)
01/29/2008CA2093808C Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
01/10/2008US20080009470 Acremonic Acid Derivatives
01/08/2008CA2196690C Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function
12/2007
12/05/2007CN100352830C Process for preparing guggulsterones and guggulsterol
11/2007
11/29/2007US20070274980 Compositions of less immunogenic and long-circulating protein-lipid complexes
11/21/2007CN101076538A Steroids for cancer treatment
11/06/2007US7291610 Estrogenic compounds as anti-mitotic agents
10/2007
10/24/2007EP1847548A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
10/04/2007WO2007051468A3 Preparation of an antibiotic crystalline fusidic acid
08/2007
08/22/2007CN1332974C Nevol anti-estrogenic steroids, and associated pharmaceutical compositions and method of use
08/21/2007CA2387600C Novel fusidic acid derivatives
08/14/2007CA2421302C 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds
07/2007
07/31/2007CA2223397C Novel nor-pregnanes for inducing hypothalamic effects
06/2007
06/20/2007CN1322002C Methylene-4-azasteroids
06/19/2007CA2281844C Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
05/2007
05/10/2007WO2007051468A2 Preparation of an antibiotic crystalline fusidic acid
05/10/2007US20070105826 Novel fusidic acid derivatives
05/08/2007CA2258177C 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
03/2007
03/08/2007US20070055072 Process for preparing guggulsterones and guggulsterol
03/06/2007US7186728 Methylene-4-azasteroids
02/2007
02/08/2007US20070032462 Novel methods for the preparation of dhea derivatives
02/06/2007US7173144 Saponifying a fatty ester in a crude phytosterol composition derived from a vegetable fat and/or oil with an alkali; practically and efficiently obtaining highly pure phytosterol
01/2007
01/04/2007WO2005077968B1 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
01/02/2007CA2168850C Estrogenic compounds as anti-mitotic agents
12/2006
12/19/2006CA2365083C Process for producing 4,4-dimethyl-3.beta.-hydrocypregna-8,14-diene-21-carboxylic acid esters and intermediate products obtained by said process
12/06/2006CN1875031A Acremonic acid derivatives
11/2006
11/16/2006WO2005077968A8 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
11/02/2006EP1716166A2 17-methylene- or 17-spiro-cyclopropane 7-substituted estra-1,3,5(10)-triene derivatives with anti-estrogenic activity
10/2006
10/18/2006EP0914165B1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms
09/2006
09/21/2006US20060211857 6,7-Oxygenated steroids and uses related thereto
09/19/2006US7109187 Estrogenic compounds as anti-mitotic agents
08/2006
08/31/2006WO2005077968A3 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
08/23/2006CN1821263A Intermediates for 16 beta -methyl steroids
08/17/2006US20060183727 Estrogenic compounds as anti-mitotic agents
08/09/2006CN1816560A Novel fusidic acid derivatives
07/2006
07/19/2006EP1680440A1 Acremonic acid derivatives
07/05/2006CN1262560C 4-halogenated 17-methylene steroids, method for production thereof and pharmaceutical compositions contg. these compounds
06/2006
06/28/2006CN1795201A Process for preparing guggulsterones and guggulsterol
06/27/2006US7067682 6,7-Oxygenated steroids and uses related thereto
05/2006
05/24/2006EP1658305A1 Novel fusidic acid derivatives
04/2006
04/19/2006CN1252081C Intermediate for preparation of 16 Beta-methyl steroids
04/18/2006CA2150738C Process for preparing a 16.beta.-methyl steroid and new intermediates
04/12/2006EP1409513B1 Methylene-4-azasteroids
03/2006
03/29/2006EP1640009A1 Estrogenic compounds as antimitotic agents
03/14/2006US7012070 Estrogenic compounds as anti-mitotic agents
03/08/2006EP1631580A2 Methods for the preparation of dhea derivatives
03/08/2006EP1423407B1 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds
02/2006
02/01/2006EP1620455A1 Process for preparing guggulsterones and guggulsterol
01/2006
01/31/2006US6993229 Method of making spun optical fiber with low PMD
12/2005
12/21/2005EP0713393B1 Estrogenic compounds as anti-angiogenesis agents
09/2005
09/27/2005US6949533 use in treating asthma, allergy, arthritis and thrombosis
08/2005
08/24/2005EP1226156B1 Process for producing phytosterols by saponification in an alcohol/water solvent
08/03/2005EP1287017B1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
06/2005
06/23/2005WO2005042422A3 Optical fiber with low pmd and method of making it by spinning
06/08/2005EP1172371B1 Process for the preparation of steroid derivatives
06/02/2005WO2005049634A1 Acremonic acid derivatives
06/02/2005CA2544769A1 Acremonic acid derivatives
05/2005
05/12/2005WO2005042422A2 Optical fiber with low pmd and method of making it by spinning
04/2005
04/05/2005US6875758 Method of treating hyperlipidemic and hyperglycemic conditions in mammals using pregnadienols and pregnadienones
04/05/2005CA2170286C Synthesis of 17-(3-pyridyl) steroids
03/2005
03/31/2005WO2002042319A9 2-substituted estrogens as antiangiogenic agents
03/31/2005US20050069267 Method of making spun optical fiber with low PMD
03/17/2005WO2005007669A8 Novel fusidic acid derivatives
02/2005
02/15/2005US6855836 5 alpha-reductase inhibitors; contraceptives; prostate disease treatments
02/02/2005CN1187365C Use of 9-alpha-hydroxyl-17-methylene steroids in prepn. of corticosteroids
01/2005
01/27/2005WO2005007669A1 Novel fusidic acid derivatives
01/27/2005CA2532725A1 Novel fusidic acid derivatives
12/2004
12/16/2004WO2004091474A3 Methods for the preparation of dhea derivatives
12/09/2004US20040248921 Reducing androgen levels; acne, prostate diseases, alopecia, hirsutism; such as 17-chloromethylene-4-aza-5-alpha-estran-3-one
12/07/2004CA2156734C Ozonide reducing agent
11/2004
11/24/2004CN1549822A Methylene-4-azasteroids
11/10/2004CN1174751C Method for preventing and curing skid aging
1 2 3 4 5 6 7 8